In contrast to interventions with a high benefit to harm ratio and clearly discernible treatment choices, PSA screening is a preference sensitive intervention for which there is a reasonable basis to screen or not screen. Thus, shared decision making plays a significant role in both a decision to screen and prostate cancer management, if diagnosed. This bilateral information sharing mitigates the high rates of over diagnosis and over treatment related to PSA screening and is an important component of high-quality health care delivery.

Contact hours available until 10/26/17.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures:
• Gina Powley - Astellas/Medivation speaker bureau, Ferring Pharmaceuticals speaker bureau
• Leanne Schimke, MSN, CRNP, CUNP - Consultant: Bayer, Speaker's Bureau: Bayer
• Valre Welch, MSN, CPNP - Holister Continence Care Advisory Board; Speaker for Hollister Incontinence Workshops

Speaker Disclosures:
There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Objectives:
1. Enable all members of the care team to recognize the importance of shared decision making and to establish a process pattern to offer it to all.
2. Identify appropriate shared decision making tools and techniques and adopt those in their practices.
3. Identify key elements of SDM.

Danil V. Makarov MD, MHS

Appearances